CHASE INVESTMENT COUNSEL CORP

Position in ZTS — Zoetis Inc.

CIK 19475 CHARLOTTESVILLE, VA

Position in ZTS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$294,554

-$1,717,039 QoQ

Shares Held

4,099

-66.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#922

of 1,408 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

CHASE INVESTMENT COUNSEL CORP holds $10,003,660 across 4 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	129,734	$5,322,986
2	LNTH	Lantheus Holdings, Inc.	20,000	$2,218,800
3	UTHR	UNITED THERAPEUTICS Corp	4,000	$2,167,320
4	ZTS	Zoetis Inc. This page	4,099	$294,554

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$294,554	4,099	-66.1%	Shares	Sole	2026-08-06
2023-03-31	$2,011,593	12,086	+10.4%	Shares	Sole	2023-05-04
2022-12-31	$1,604,722	10,950	-1.9%	Shares	Sole	2023-01-25
2022-09-30	$1,655,064	11,161	-0.8%	Shares	Sole	2022-10-31
2022-06-30	$1,933,762	11,250	-3.0%	Shares	Sole	2022-07-26
2022-03-31	$2,186,701	11,595	-30.6%	Shares	Sole	2022-04-21
2021-12-31	$4,079,205	16,716	-0.1%	Shares	Sole	2022-02-02
2021-09-30	$3,248,932	16,735	-8.3%	Shares	Sole	2021-11-04
2021-06-30	$3,402,374	18,257	+1.1%	Shares	Sole	2021-07-29
2021-03-31	$2,845,033	18,066	-2.4%	Shares	Sole	2021-05-06
2020-12-31	$3,063,239	18,509	-29.9%	Shares	Sole	2021-02-02
2020-09-30	$4,367,917	26,413	-6.4%	Shares	Sole	2020-11-03
2020-06-30	$3,868,228	28,227	-12.5%	Shares	Sole	2020-08-05
2020-03-31	$3,795,855	32,253	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.